Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-05-08

Clinical Trial Update: Equitable Smoking Relapse Prevention [NA]

View source ↗

Summary

The clinical trial Equitable Smoking Relapse Prevention (NCT05625685) related to tobacco use disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Bryan W. Heckman | Conditions: Tobacco Use Disorder, Tobacco Dependence | NA | Status: WITHDRAWN